Mizukami Takuo

Research theme for competitive and other funds (1)：

Papers (49)：

Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Takayuki Matsumura, Yoshimasa Takahashi, Isao Hamaguchi. Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site. Mucosal immunology. 2023
Eita Sasaki, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi. An investigation and assessment of the muscle damage and inflammation at injection site of aluminum-adjuvanted vaccines in guinea pigs. The Journal of toxicological sciences. 2022. 47. 11. 439-451
Eita Sasaki, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi. Impact of injection buffer volume to perform bronchoalveolar lavage fluid collection for isolating alveolar macrophages to investigate fine particle-induced IL-1α secretion. Journal of immunotoxicology. 2021. 18. 1. 163-172
Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi. Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses. PLoS pathogens. 2021. 17. 8. e1009890
Kenta Tezuka, Naoki Fuchi, Kazu Okuma, Takashi Tsukiyama, Shoko Miura, Yuri Hasegawa, Ai Nagata, Nahoko Komatsu, Hiroo Hasegawa, Daisuke Sasaki, et al. HTLV-1 targets human placental trophoblasts in seropositive pregnant women. Journal of Clinical Investigation. 2020. 130. 11. 6171-6186

ｍore...

MISC (19)：

水上拓郎, 百瀬暖佳, 佐々木永太, 古畑啓子, 楠英樹, 浅沼秀樹, 濱口功. Reverse toxicology for identifying novel, safe, and effective vaccine adjuvants. Journal of Toxicological Sciences. 2020. 45. Supplement
大隈和, 倉光球, 手塚健太, 水上拓郎, 村田めぐみ, 明里宏文, 浜口功. サル感染モデルを用いたHTLV-1治療薬評価に向けた検討. 日本実験動物学会総会講演要旨集(Web). 2019. 66th
大隈和, 倉光球, 手塚健太, 水上拓郎, 村田めぐみ, 明里宏文, 浜口功. 組換えVSVによる抗HTLV-1ウイルス療法の開発に向けたSTLV-1感染ニホンザルのHTLV-1感染霊長類モデルへの応用. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2019. 67th
手塚健太, 水上拓郎, 佐々木永太, 倉光球, 松岡佐保子, 大隈和, 浜口功. ヒト化マウスモデルを用いた高感度HTLV-1ウイルスRNA検出法の開発. 日本実験動物学会総会講演要旨集(Web). 2019. 66th
大隈和, 手塚健太, 北村知也, 倉光球, 水上拓郎, 村田めぐみ, 明里宏文, 浜口功. HTLV-1感染に対するウイルス療法確立に向けた腫瘍溶解性VSVの霊長類薬剤評価系の構築. 日本HTLV-1学会学術集会. 2019. 6th

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page